Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma

Conclusions: Here, we present the first RNA-seq prognostic signature for lung adenocarcinoma that can provide a powerful prognostic tool for precision oncology as part of an integrated RNA-seq clinical sequencing program.

Source: JNCI - October 4, 2016 Category: Cancer & Oncology Authors: Shukla, S., Evans, J. R., Malik, R., Feng, F. Y., Dhanasekaran, S. M., Cao, X., Chen, G., Beer, D. G., Jiang, H., Chinnaiyan, A. M. Tags: Article Source Type: research